COVID-19

Latest News

Long COVID definition variability remains inconsistent, resulting in delayed recognition, documentation, and treatment. | Image Credit: AdobeStock_tilialucida.jpeg
Variable Long COVID Definitions Create Hurdles in Care, Research

August 12th 2025

There is a need to consolidate various long COVID definitions to establish a standardized definition that ensures consistent recognition, documentation, diagnosis, and treatment, according to new research.

Updated mRNA Vaccines Against JN.1 Show Strong Safety Signal in Real-World Data
Updated mRNA Vaccines Against JN.1 Show Strong Safety Signal in Real-World Data

July 31st 2025

Long COVID graphic | Image Credit: Parradee - stock.adobe.com
Long COVID More Common Among Socially Vulnerable Individuals

July 28th 2025

COVID-19 vaccine for patients with cancer. | Image Credit: Framestock - stock.adobe.com
COVID-19 Boosters Crucial for Patients With Cancer Despite Low Uptake

July 17th 2025

COVID-19 3D rendering | Image Credit: Production Perig - stock.adobe.com
Severe COVID-19 Linked to Higher Exacerbation, Mortality Risks in Patients With Bronchiectasis

July 8th 2025

Continuing Medical Education
View All
August 20th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
August 20th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

Contributor: COVID-19 Fell in Rank Among Telehealth Diagnoses Nationally in September 2022
December 6th 2022

Contributor: COVID-19 Fell in Rank Among Telehealth Diagnoses Nationally in September 2022

Robin Gelburd, JD
According to the most recent data from FAIR Health, COVID-19 telehealth diagnoses declined in 3 of the 4 census regions in the United States.
Samyukta Mullangi, MD, MBA, Memorial Sloan Kettering Cancer Center
December 1st 2022

Dr Samyukta Mullangi: COVID-19 Has Spurred Us to Ask How We Can Innovate Care Delivery

Maggie L. Shaw Mary Caffrey
During an Institute for Value-Based Medicine® event held in New York City, Samyukta Mullangi, MD, MBA, fellow in medical oncology at Memorial Sloan Kettering Cancer Center, discussed how disruptions from the COVID-19 pandemic are ushering in health care delivery reform.
Image of a hospital bed
November 26th 2022

Nirmatrelvir-Ritonavir Highly Effective at Preventing COVID-19 Hospitalization, RWE Says

Jared Kaltwasser
The study of real-world evidence (RWE) found nearly 9 in 10 patients in a highly vaccinated cohort avoided hospitalization within 15 days of treatment for COVID-19.
COVID-19
November 23rd 2022

Nirmatrelvir-Ritonavir Shows Safety, Efficacy in Real-world Study of High-risk COVID-19 Patients

Rose McNulty
The retrospective study evaluated outcomes in patients prescribed nirmatrelvir-ritonavir, as well as the management of drug interactions by clinical pharmacists prescribing the regimen.
covid-19
November 19th 2022

Researchers Point to IL-26 as Biomarker of Severe COVID-19

AJMC Staff
High levels of interleukin (IL)-26 levels correlate with an exaggerated inflammatory response that signifies severe cases of the disease, according to researchers.
Robin Gelburd
November 11th 2022

Contributor: COVID-19 Fell in Rank Among Telehealth Diagnoses in South and West in August 2022

Robin Gelburd, JD
Telehealth diagnoses in the South and West regions of the United States saw a reduction in COVID-19 diagnoses.
What We're Reading
November 10th 2022

What We’re Reading: Listeria Outbreak; COVID-19 Death Decline; Eli Lilly Pays in Drug Patent Trial

Julia Bonavitacola
A listeria outbreak has been linked to deli meats and cheeses; the World Health Organization announced that there has been a 90% drop in recent deaths in COVID-19 globally compared with 9 months ago; Eli Lilly was ordered to pay $176.5 million in a US migraine drug patent trial.
What We're Reading
November 8th 2022

What We’re Reading: VA to Prioritize Cancer Claims; Pfizer’s COVID-19 Cash; Medicaid Coverage Concerns

AJMC Staff
The Department of Veterans Affairs (VA) will give cancer claims priority when a new law takes effect in January 2023; Pfizer is looking to use its COVID-19 profits to grow other blockbusters; the probable loss of Medicaid coverage for millions next year is setting off debate.
Contributor: COVID-19 Ranked Among the Top 5 Telehealth Diagnoses Nationally in April 2022
July 6th 2022

Contributor: COVID-19 Ranked Among the Top 5 Telehealth Diagnoses Nationally in April 2022

Robin Gelburd, JD
COVID-19 was ranked in the top 5 diagnoses through telehealth in the Midwest, Northeast, and West regions as well as nationally in the month of April, coinciding with an increase in COVID-19 cases.
Population data.
June 24th 2022

What’s Next in Health Care? Panelists Highlight Data, Partnerships Post-COVID-19

Matthew Gavidia
Panelists of an AHIP 2022 session discussed how future policy, infrastructure, and investment strategies in public health will reinforce the efforts already made during the pandemic, with partnerships and engagement key to optimize innovation.
Robin Gelburd, JD
May 9th 2022

Contributor: COVID-19 Falls Out of Top 5 Telehealth Diagnoses in February 2022

Robin Gelburd, JD
The February drop out of the top 5 coincided with a sharp decline in new cases of COVID-19, as reported by the CDC, following the January peak of the wave of cases related to the Omicron variant.
EBO
February 14th 2022

Telehealth at Minnesota Oncology: Tackling COVID-19, Educating Patients, and Overcoming the Weather

Mary Caffrey
Rajini Katipamula-Malisetti, MD, a medical oncologist and hematologist with Minnesota Oncology who practices in Coon Rapids, has seen telehealth’s usefulness up close. During a pandemic, it can increase the number of touch points in areas such as survivorship care and nutrition, which would otherwise require a separate visit to the office.
Contributor: COVID-19 Among the Top 5 Telehealth Diagnoses in the US in November 2021
February 7th 2022

Contributor: COVID-19 Among the Top 5 Telehealth Diagnoses in the US in November 2021

Robin Gelburd, JD
doctor holding a test tube with a clear liquid and the world "coronavirus" superimposed on top
January 26th 2022

Study Supports Pfizer, Moderna COVID-19 Vaccines’ Safety in Patients With Multiple Myeloma

Skylar Jeremias
Study results showed that both the Pfizer-BioNTech and Moderna COVID-19 vaccines were safe and effective in patients with multiple myeloma, which investigators hope will improve vaccine hesitancy in the high-risk population.
Decline Seen in National Telehealth Utilization in October 2021
January 10th 2022

Decline Seen in National Telehealth Utilization in October 2021

Robin Gelburd, JD
Peter Hotez, MD
December 21st 2021

Dr Peter Hotez on Combatting Antivaccination Beliefs and Rescuing Public Health From Politics

Maggie L. Shaw Allison Inserro
In an interview conducted before the highly transmissible Omicron coronavirus variant began driving another wave of infections, Peter Hotez, MD, PhD, FASTMH, discussed the struggle public health officials and scientists have in fighting false beliefs about vaccinations.
The American Journal of Accountable Care
December 10th 2021

Telehealth User Experiences During COVID-19: A Case Study of Outpatient Cardiovascular Clinics Affiliated With a Large Academic Practice

Megan Lee, BS Paulina Luna, MS Shannon Lynch, FNP Sameer Nagpal, MD Yulanka Castro-Dominguez, MD Zain Ahmed, MD Aaron Brice, MD Ahmad Arham, MD Kim G. Smolderen, PhD Carlos Mena-Hurtado, MD
In cardiovascular clinics during COVID-19, notable barriers to successful telehealth use included obtaining diagnostic information needed to deliver high-quality care and technology-related challenges for patients.
To Prevent the Next Pandemic, Fight Antiscience Beliefs, Hotez Says
November 7th 2021

To Prevent the Next Pandemic, Fight Antiscience Beliefs, Hotez Says

Allison Inserro
While low- and middle-income countries remain desperate for a COVID-19 vaccine, the United States has entered a dangerous new phase of the pandemic, where antivaccine forces are exporting their antiscience beliefs to other countries, according to a keynote speaker at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
An Increase in Telehealth Utilization in the South From July to August 2021
November 2nd 2021

An Increase in Telehealth Utilization in the South From July to August 2021

Robin Gelburd, JD
The August telehealth growth coincided with the peak of the surge in COVID-19 cases driven by the Delta variant in the South.
Efficacy of COVID-19 Vaccines in Real-World Settings Even Better Than Expected, Fauci Says
May 16th 2021

Efficacy of COVID-19 Vaccines in Real-World Settings Even Better Than Expected, Fauci Says

Allison Inserro
Anthony Fauci, MD, told attendees at the ATS 2021 International Conference that the real-world evidence of vaccines against SARS-CoV-2, the virus that causes COVID-19, is even better than expected.
What We're Reading: Pfizer Vaccine Lessens Hospitalization, Death Risk; 6M Doses Delayed; Mental Health in Coronavirus Survivors
February 22nd 2021

What We're Reading: Pfizer Vaccine Lessens Hospitalization, Death Risk; 6M Doses Delayed; Mental Health in Coronavirus Survivors

AJMC Staff
Pfizer/BioNTech vaccine shown to prevent most coronavirus disease 2019 (COVID-19)–related deaths or hospitalizations; extreme weather delays 6 million vaccine doses; post-traumatic stress disorder and anxiety seen in COVID-19 survivors.
<12345>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo